| Oct 29, 2010
| 9:40 AM
WASHINGTON (AP) — Drugmaker Pfizer Inc. announced Friday it would recall 38,000 bottles of its blockbuster cholesterol drug Lipitor due to an unpleasant odor, the third recall this year related to the problem.
The New York-based drugmaker said...
| Nov 29, 2011
| 4:22 PM
The nation's largest-selling pharmaceutical is going generic this week. Lipitor, which is prescribed to help people reduce their cholesterol levels, is going "off-patent" Wednesday. According to a HealthDay News report, Lipitor sales were nearly $4...
| Apr 19, 2010
When the oral contraceptives Yasmin and Yaz came on the market in 2001 and 2006, respectively, they were thought to be safer than other birth control pills because they contained a different kind of synthetic progestin.
But in a flurry of lawsuits...
| May 25, 2010
| 12:18 PM
WASHINGTON (AP) — Federal health regulators are warning doctors and patients that popular heartburn drugs like Nexium and Prilosec may cause bone fractures when used for more than a year.
The Food and Drug Administration said Tuesday several...
| Jun 16, 2010
| 8:41 PM
WASHINGTON -- A pink pill designed to boost sex drive in women -- the latest attempt by the drug industry to find a female equivalent to Viagra -- fell short in two studies, federal health regulators said Wednesday.
The Food and Drug Administration is...
| Jan 18, 2010
In a quest to look younger, be healthier and feel more vital later in life, increasing numbers of men, just like Jeffry Life, are turning to testosterone and human growth hormone. Use of both hormones is controversial. Read on:
Testosterone: "Older men ....
| Oct 31, 2010
| 11:04 AM
WASHINGTON (AP) — Fifty years after the pill, another birth control revolution may be on the horizon: free contraception for women in the U.S., thanks to the new health care law.
That could start a shift toward more reliable — and expensive...
| Jul 13, 2010
| 1:59 PM
The diabetes pill Avandia has been used by millions of patients and racked up billions in sales in more than a decade on the market. This week the Food and Drug Administration is trying to answer a seemingly simple question: Does it cause heart attacks?...
| Jul 9, 2010
| 1:34 PM
A review by federal health scientists reinforces potential ties between the diabetes pill Avandia and heart attack and death, opening the door for government action, including a possible withdrawal of the once blockbuster drug.
The Food and Drug...
| Jul 15, 2010
Faced with conflicting and less-than-conclusive scientific evidence, a Food and Drug Administration advisory panel recommended Wednesday that the controversial diabetes drug Avandia remain on the market — but with tighter supervision and increased...
| Aug 9, 2010
As the world's most-prescribed class of medications, statins indisputably qualify for the commercial distinction of "blockbuster." About 24 million Americans take the drugs — marketed under such commercial names as Pravachol, Mevacor, Lipitor, Zocor...